Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

This publication has 19 references indexed in Scilit:

• Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
  Annals of Oncology, 2005
• New options and old dilemmas in the treatment of patients with advanced colorectal cancer
  Annals of Oncology, 2004
• Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment
  Journal of Clinical Oncology, 2004
• Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
  Journal of Clinical Oncology, 2003
• Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study
  Journal of Clinical Oncology, 2001
• Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
  Journal of Clinical Oncology, 2001
• Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
  New England Journal of Medicine, 2000
• Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
  Journal of Clinical Oncology, 2000
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
  Published by Elsevier ,2000
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
  The Lancet, 1998